TY - JOUR T1 - Correlation of rate of serum albumin decline with other acute phase reactants and effect of current treatment options on serum albumin level in COVID-19 JF - Journal of Investigative Medicine JO - J Investig Med SP - 1259 LP - 1259 DO - 10.1136/jim-2021-001881 VL - 69 IS - 6 AU - Simrat Kaur Batth Y1 - 2021/08/01 UR - http://hw-f5-jim.highwire.org/content/69/6/1259.abstract N2 - Dear Editor,I have read the study “ALLY in fighting COVID-19: magnitude of albumin decline and lymphopenia (ALLY) predict progression to critical disease”1 with great interest but would like to bring some issues to the notice of the readers.First, the study used a comorbidity score to calculate the number of comorbidities present at admission out of asthma, coronary artery disease, chronic obstructive pulmonary disease, diabetes mellitus, hypertension, cancer, history of renal disease, and smoking.1 ⁠ Liver disease has not been considered in the comorbidity scale, which can greatly … ER -